Effects of lipopolysaccharide on P-glycoprotein expression and activity in the liver and kidneys

European Journal of Pharmacology

Volumn 636, Issue 1-3, 2010, Pages 155-158

  Kato, Ryuji ^a   Moriguchi, Jun ^a   Irie, Takako ^a   Nakagawa, Machiko ^a   Kusukawa, Yugo ^a   Matsumura, Hitoshi ^a   Ijiri, Yoshio ^a   Tanaka, Kazuhiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Kidney; Lipopolysaccharide; Liver; P glycoprotein; Rhodamine 123

Indexed keywords

GLYCOPROTEIN P; LIPOPOLYSACCHARIDE; RHODAMINE 123;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE; CONTROLLED STUDY; KIDNEY; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; URINARY EXCRETION; WESTERN BLOTTING;

ANIMALS; GENE EXPRESSION REGULATION; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; MALE; P-GLYCOPROTEIN; RATS; RATS, WISTAR; RHODAMINE 123; TIME FACTORS;

EID: 77952671279     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.03.024     Document Type: Article

References (12)

1. Ando H., Nishio Y., Ito K., Nakao A., Wang L., Zhao Y.L., Kitaichi K., Takagi K., Hasegawa T. Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats. Antimicrob. Agents Chemother. 2001, 45:3462-3467.
2. Cherrington N.J., Slitt A.L., Li N., Klaassen C.D. Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab. Dispos. 2004, 32:734-741.
3. Hartmann G., Vassileva V., Piquette-Miller M. Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice. Drug Metab. Dispos. 2005, 33:820-828.
4. Hidemura K., Zhao Y.L., Ito K., Nakao A., Tatsumi Y., Kanazawa H., Takagi K., Ohta M., Hasegawa T. Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2. Antimicrob. Agents Chemother. 2003, 47:1636-1642.
5. Huang Z.H., Murakami T., Okochi A., Yumoto R., Nagai J., Takano M. Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure. Eur. J. Pharmacol. 2000, 406:453-460.
6. Miyoshi M., Nadai M., Nitta A., Ueyama J., Shimizu A., Takagi K., Nabeshima T., Takagi K., Saito K., Hasegawa T. Role of tumor necrosis factor-α in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin. Eur. J. Pharmacol. 2005, 507:229-237.
7. Moriguchi J., Kato R., Nakagawa M., Hirotani Y., Ijiri Y., Tanaka K. Effects of lipopolysaccharide on intestinal P-glycoprotein expression and activity. Eur. J. Pharmacol. 2007, 565:220-224.
8. Parasrampuria R., Mehvar R. Hepatobiliary disposition of rhodamine 123 in isolated perfused rat livers. Xenobiotica 2008, 38:1263-1273.
9. Piquette-Miller M., Pak A., Kim H., Anari R., Shahzamani A. Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation. Pharm. Res. 1998, 15:706-711.
10. Sun H., Frassetto L., Benet L.Z. Effects of renal failure on drug transport and metabolism. Pharmacol. Ther. 2006, 109:1-11.
11. Vos T.A., Hooiveld G.J., Koning H., Childs S., Meijer D.K., Moshage H., Jansen P.L., Müller M. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 1998, 28:1639-1644.
12. Zhang W., Tan T.M., Lim L.Y. Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats. Drug Metab. Dispos. 2007, 35:110-115.